30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Morl Christopher John

Track

Insider profile

Morl Christopher John's trades of Deciphera Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-01-17 2020-01-16
PlS Planned sale
1,242 +30.5%
138.63
US$2,385,930 		1,242 +30.5% 138.63 US$2,385,930
2020-01-17 2020-01-15
PlS Planned sale
71,564 -26.1%
291.80
US$3,192,031 		71,564 -26.1% 291.80 US$3,192,031
2020-01-09 2020-01-08
PlS Planned sale
52,654 +6.2%
406.80
US$1,842,097 		52,654 +6.2% 406.80 US$1,842,097
2020-01-09 2020-01-07
PlS Planned sale
1,650 -100.0%
60.02
US$99,035 		1,650 -100.0% 60.02 US$99,035
2020-01-06 2020-01-02
PlS Planned sale
400 -100.0%
62.25
US$24,900 		400 -100.0% 62.25 US$24,900
2020-01-06 2020-01-02
PlS Planned sale
800 -66.7%
61.58
US$49,266 		800 -66.7% 61.58 US$49,266
2020-01-06 2020-01-02
PlS Planned sale
800 -40.0%
60.58
US$48,463 		800 -40.0% 60.58 US$48,463
2020-01-06 2020-01-02
PlS Planned sale
2,103 -51.3%
59.48
US$125,087 		2,103 -51.3% 59.48 US$125,087
2020-01-06 2020-01-02
PlS Planned sale
3,529 -46.2%
58.38
US$206,039 		3,529 -46.2% 58.38 US$206,039
2020-01-06 2020-01-02
PlS Planned sale
8,505 -52.7%
57.74
US$491,117 		8,505 -52.7% 57.74 US$491,117